Intelligence · Clinical pipeline
Autoimmune & immunology · Approved programs
Autoimmune & immunology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Autoimmune & immunology Approved programs programs: NovaPharmaNews indexes 84 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 14 programs
- Chinese Academy of 9 programs
- Disc Medicine 8 programs
- George Institute for 6 programs
- United Therapeutics Europe 4 programs
- Hospital Authority 3 programs
- Pfizer 3 programs
- Anaxis Pharma 2 programs
- Chinese University of 2 programs
- Eli Lilly and 2 programs
- First People's Hospital 2 programs
- International Peace Maternity 2 programs
Pipeline programs
-
2024-517112-30-00
Disc Medicine
Rheumatoid arthritis
1 trial -
300128
HALEON AUSTRALIA PTY LTD
Mild/non-serious osteoarthritis (OA) of the knee.
1 trial -
ABBV-066, DEUCRAVACITINIB
AbbVie Deutschland GmbH & Co. KG
Plaque Psoriasis
1 trial -
ADALIMUMAB , INFLIXIMAB
Disc Medicine
Crohn's disease Ulcerative colitis
1 trial -
ADIPGEN
The George Institute
Knee Osteoarthritis
1 trial -
APHP 190183
Pari Pharma GmbH
Crohn’s disease
1 trial -
Adalimumab
Takeda
Crohn's Disease
1 trial -
Alofisel 5 × 106 cells/mL dispersion for injection.
Takeda
Perianal fistulising Crohn´s disease
1 trial -
Baricitinib 4 MG
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial -
Benlysta 200 mg solution for injection in pre-filled pen.
GlaxoSmithKline
Systemic Lupus Erythematosus
1 trial -
Buprenorphine transdermal patch
Mundipharma Pty Limited
Osteoarthritis
1 trial -
CAIN457I2401
Novartis Pharmaceuticals
non-radiographic axial spondyloarthritis
1 trial -
CDPATH™
Takeda
Crohn's Disease
1 trial -
CNTO1959PSA4002
Janssen-Cilag International N.V.
Psoriatic Arthritis
1 trial -
Caffeine
Takeda
Colitis, Ulcerative
1 trial -
Celecoxib
Pfizer
Arthritis, Juvenile Rheumatoid
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Crohn Disease
1 trial -
Colquhounia Root Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
Darvadstrocel
Takeda
Crohn's Disease
3 trials -
DePuy ASR Hip System
International Peace Maternity and Child Health Hospital
Rheumatoid Arthritis
1 trial -
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
ETN Alone
Universal Integrated
Rheumatoid Arthritis
1 trial -
Enbrel powder and solvent for Juvenile Idiopathic Arthritis
Fondazione Telethon ETS
Juvenile Idiopathic Arthritis
1 trial -
Etanercept
Pfizer
Moderate to Severe Psoriasis
1 trial -
Etanercept , Methotrexate
Wyeth is now a wholly owned subsidiary of Pfizer
Rheumatoid Arthritis
1 trial -
Filgotinib
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
8 trials -
Foliumzuur Aurobindo for Psoriatic arthritis
Disc Medicine
Psoriatic arthritis
1 trial -
GadoCrohn
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Guli capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Guselkumab
Janssen Cilag International NV
Arthritis, Psoriatic
3 trials -
I4V-MC-JAJA
Eli Lilly Co.
Rheumatoid Arthritis
1 trial -
I6T-MC-AMCA
Eli Lilly Co.
severely active ulcerative colitis (US) and CD (Crohn’s disease)
1 trial -
IDEA
CERO THERAPEUTICS HOLDINGS, INC.
Ulcerative Colitis
1 trial -
IM011-1130
Bristol-Myers Squibb Australia Pty Ltd
Moderate to Severe Plaque Psoriasis
1 trial -
Infliximab
The First People's Hospital of Lianyungang
Crohn's Diseases
1 trial -
Ixekizumab
Hospital Authority, Hong Kong
Plaque Psoriasis
1 trial -
KCT23/2022-ZOOM-IN
Novo Nordisk A/S
Knee osteoarthritis
1 trial -
Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.
Disc Medicine
autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA
1 trial -
LCS® Complete™ Mobile Bearing Knee Systems
International Peace Maternity and Child Health Hospital
Knee Osteoarthritis
1 trial -
LP0160-1329
LEO Pharma A/S
Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
1 trial -
MMX Mesalamine
Takeda
Ulcerative Colitis
2 trials -
MMX mesalamine/ mesalazine
Takeda
Ulcerative Colitis
1 trial -
Mesalazine
The First People's Hospital of Lianyungang
Ulcerative Colitis, Unspecified
1 trial -
Methotrexate
United Therapeutics Europe Ltd
Psoriatic Arthritis
1 trial -
Methotrexate plus sulfasalazine
Hospital Authority, Hong Kong
Rheumatoid Arthritis
1 trial -
Methylprednisolone and Mycophenolate mofetil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hepatitis
1 trial -
NORD-STAR
The George Institute
Rheumatoid Arthritis
1 trial -
PRIMERA001
Disc Medicine
Rheumatoid arthritis according to 2010 criteria
1 trial
Frequently asked questions
How many autoimmune & immunology Approved programs programs exist?
84 programs match both the therapeutic area and stage filters in our published index.